Similarly, mice that are null for the ubiquitin ligase FBXO32 (atrogin-1) experience a higher loss of muscle mass and strength during aging than do controls14, contrary to the expectation that they would be protected from sarcopenia. Here, FBXO32 is linked to sarcopenia.